217 related articles for article (PubMed ID: 26716643)
1. Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95.
Das A; Durrant D; Mitchell C; Dent P; Batra SK; Kukreja RC
Oncotarget; 2016 Jan; 7(4):4399-413. PubMed ID: 26716643
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction.
Das A; Durrant D; Mitchell C; Mayton E; Hoke NN; Salloum FN; Park MA; Qureshi I; Lee R; Dent P; Kukreja RC
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18202-7. PubMed ID: 20884855
[TBL] [Abstract][Full Text] [Related]
3. The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Matsuyoshi S; Konishi N
Mol Carcinog; 2004 Jan; 39(1):1-9. PubMed ID: 14694442
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis.
Hyer ML; Sudarshan S; Kim Y; Reed JC; Dong JY; Schwartz DA; Norris JS
Cancer Biol Ther; 2002; 1(4):401-6. PubMed ID: 12432255
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
6. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression.
Kelly MM; Hoel BD; Voelkel-Johnson C
Cancer Biol Ther; 2002; 1(5):520-7. PubMed ID: 12496481
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.
Mallappa S; Neeli PK; Karnewar S; Kotamraju S
Mol Carcinog; 2019 Jul; 58(7):1118-1133. PubMed ID: 30834613
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes.
Nitobe J; Yamaguchi S; Okuyama M; Nozaki N; Sata M; Miyamoto T; Takeishi Y; Kubota I; Tomoike H
Cardiovasc Res; 2003 Jan; 57(1):119-28. PubMed ID: 12504821
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract][Full Text] [Related]
11. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells.
Friesen C; Fulda S; Debatin KM
Leukemia; 1997 Nov; 11(11):1833-41. PubMed ID: 9369415
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression.
Kinoshita H; Yoshikawa H; Shiiki K; Hamada Y; Nakajima Y; Tasaka K
Int J Cancer; 2000 Dec; 88(6):986-91. PubMed ID: 11093825
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation.
Bian X; Giordano TD; Lin HJ; Solomon G; Castle VP; Opipari AW
J Biol Chem; 2004 Feb; 279(6):4663-9. PubMed ID: 14617634
[TBL] [Abstract][Full Text] [Related]
14. Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation.
Zhang G; Park MA; Mitchell C; Hamed H; Rahmani M; Martin AP; Curiel DT; Yacoub A; Graf M; Lee R; Roberts JD; Fisher PB; Grant S; Dent P
Clin Cancer Res; 2008 Sep; 14(17):5385-99. PubMed ID: 18765530
[TBL] [Abstract][Full Text] [Related]
15. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel.
Symes JC; Kurin M; Fleshner NE; Medin JA
Mol Cancer Ther; 2008 Sep; 7(9):3018-28. PubMed ID: 18790782
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
17. c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma.
Luebke T; Schwarz L; Beer YY; Schumann S; Misterek M; Sander FE; Plaza-Sirvent C; Schmitz I
Cell Death Dis; 2019 May; 10(6):384. PubMed ID: 31097685
[TBL] [Abstract][Full Text] [Related]
18. Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells.
Ewaschuk JB; Newell M; Field CJ
Lipids; 2012 Nov; 47(11):1019-30. PubMed ID: 23054549
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling.
Wennerberg E; Sarhan D; Carlsten M; Kaminskyy VO; D'Arcy P; Zhivotovsky B; Childs R; Lundqvist A
Int J Cancer; 2013 Oct; 133(7):1643-52. PubMed ID: 23504627
[TBL] [Abstract][Full Text] [Related]
20. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
